S17-337 Hyper-Lethal Combination: Inhibiting Chromatin Remodeling as Cancer-Killing Strategy Disease indication - Cancer, specifically: -highly mutated cancers, including the ~20% of cancer with BAF complex mutations -combination therapy with ATR inhibitors Emma Chory Emily Dykhuizen Gerald Crabtree